Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
GELITA Unveils Next-Generation Excipient Innovations at BIO International 2026 in San Diego
12 Jun 2026
PR Newswire Association LLC.
Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity
12 Jun 2026
GlobeNewswire
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12 Jun 2026
PR Newswire Association LLC.
ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens
11 Jun 2026
GlobeNewswire
Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
11 Jun 2026
GlobeNewswire
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11 Jun 2026
GlobeNewswire
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
11 Jun 2026
GlobeNewswire
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
11 Jun 2026
GlobeNewswire
Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL
10 Jun 2026
PR Newswire Association LLC.
Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model
10 Jun 2026
GlobeNewswire
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
10 Jun 2026
GlobeNewswire
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
10 Jun 2026
GlobeNewswire
iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
09 Jun 2026
PR Newswire Association LLC.
Pentixapharm Holding AG: FDA grants "Study May Proceed" for Phase 3 Study; Intended Capital Increase with Subscription Rights of up to 10 Million Shares; BaFin Financial Reporting Enforcement Review of the 2024 Consolidated Financial Statements
09 Jun 2026
PR Newswire Association LLC.
[68Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market
09 Jun 2026
PR Newswire Association LLC.
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research
09 Jun 2026
PR Newswire Association LLC.
Exilby® Receives First European Marketing Authorization as VERTANICAL Prepares UK Submission for its First-in-Class Non-Opioid Treatment for Chronic Low Back Pain
09 Jun 2026
PR Newswire Association LLC.
VERTANICAL Receives First European Marketing Authorization for Exilby® as a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain - Pivotal U.S. Phase 3 trial underway
09 Jun 2026
PR Newswire Association LLC.
THE GORE® VIABAHN® FORTEGRA VENOUS STENT RECEIVES MDR APPROVAL
09 Jun 2026
GlobeNewswire
J-Star Holding Announces Successful Annual General Meeting and Reaffirms Commitment to U.S. Advanced Manufacturing Strategy
08 Jun 2026
GlobeNewswire
Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026
08 Jun 2026
PR Newswire Association LLC.
Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
08 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
PR Newswire Association LLC.
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
05 Jun 2026
Upcoming Events All Events
- June 2026
- San Diego: RESI San Diego 2026
- San Diego: BIO 2026
- July 2026
- Taipei: BIO Asia-Taiwan